A phase 2 clinical trial of pembrolizumab with radiation following progression on anti-PD-1 therapy in patients with recurrent or metastatic squamous cell carcinoma of the head and neck Meeting Abstract
| Authors: | Schoenfeld, J. D.; Chen, Y. H.; Gunasti, L.; Droznin, A.; Baginska, J.; Nau, A.; Weirather, J.; Diaz, I. G.; Margalit, D. N.; Tishler, R. B.; Fitzgerald, K. J.; Mak, R. H.; Uppaluri, R.; Sehgal, K.; Hanna, G. J.; Haddad, R. I.; So, J. |
| Abstract Title: | A phase 2 clinical trial of pembrolizumab with radiation following progression on anti-PD-1 therapy in patients with recurrent or metastatic squamous cell carcinoma of the head and neck |
| Meeting Title: | 2024 Multidisciplinary Head and Neck Cancers Symposium |
| Journal Title: | International Journal of Radiation Oncology, Biology, Physics |
| Volume: | 118 |
| Issue: | 5 |
| Meeting Dates: | 2024 Feb 29-Mar 2 |
| Meeting Location: | Phoenix, AZ |
| ISSN: | 0360-3016 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2024-04-01 |
| Start Page: | e32 |
| Language: | English |
| DOI: | 10.1016/j.ijrobp.2024.01.075 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl plus with full text |
| DOI/URL: | |
| Notes: | Meeting Abstract: 140 -- Accession Number: 175934740 -- Entry Date: In Process -- Revision Date: 20240313 -- Publication Type: Journal Article -- Journal Subset: Biomedical; Peer Reviewed; USA -- NLM UID: 7603616. -- Source: CINAHL Plus with Full Text |
